These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

74 related items for PubMed ID: 7584719

  • 1. Haloperidol and restraint differently inhibit the induction of sensitization to the ambulation-increasing effect of methamphetamine in mice.
    Kuribara H.
    Nihon Shinkei Seishin Yakurigaku Zasshi; 1995 Jun; 15(3):253-63. PubMed ID: 7584719
    [Abstract] [Full Text] [Related]

  • 2. Partial inhibition of reverse tolerance by a high dose of ritanserin or low dose of haloperidol in methamphetamine-sensitized rat.
    Tanaka T, Ishigooka J, Watanabe S, Nagata E, Miura S.
    Nihon Shinkei Seishin Yakurigaku Zasshi; 1998 Feb; 18(1):1-7. PubMed ID: 9592805
    [Abstract] [Full Text] [Related]

  • 3. Effects of haloperidol on the methamphetamine sensitization: assessment by ambulatory activity in mice.
    Kuribara H, Uchihashi Y.
    Jpn J Psychiatry Neurol; 1993 Sep; 47(3):661-8. PubMed ID: 8301885
    [Abstract] [Full Text] [Related]

  • 4. Effects of tetrabenazine on methamphetamine-induced hyperactivity in mice are dependent on order and time-course of administration.
    Kuribara H.
    Pharmacol Biochem Behav; 1997 Jan; 56(1):9-14. PubMed ID: 8981603
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Changes in G-protein activity mediated through the stimulation of dopamine and GABA(B) receptors in the mesolimbic dopaminergic system of morphine-sensitized mice.
    Narita M, Shibasaki M, Mizuo K, Suzuki T.
    Addict Biol; 2003 Sep; 8(3):319-25. PubMed ID: 13129834
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Inhibitory effect of restraint on induction of behavioral sensitization to methamphetamine and cocaine in mice.
    Kuribara H.
    Pharmacol Biochem Behav; 1996 Jun; 54(2):327-31. PubMed ID: 8743591
    [Abstract] [Full Text] [Related]

  • 10. Can posttreatment with the selective dopamine D2 antagonist, YM-09151-2, inhibit induction of methamphetamine sensitization? Evaluation by ambulatory activity in mice.
    Kuribara H.
    Pharmacol Biochem Behav; 1994 Oct; 49(2):323-6. PubMed ID: 7824544
    [Abstract] [Full Text] [Related]

  • 11. [Effects of mosapramine (Y-516), a new dopamine D2 antagonist, on reverse tolerance after repeated administration of methamphetamine by means of the ambulation-increasing effect in mice].
    Uchihashi Y, Morimoto T, Tadokoro S.
    Nihon Yakurigaku Zasshi; 1992 Mar; 99(3):153-60. PubMed ID: 1505855
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Modification by MK-801 (dizocilpine), a noncompetitive NMDA receptor antagonist, of morphine sensitization: evaluation by ambulation in mice.
    Iijima Y, Asami T, Kuribara H.
    Nihon Shinkei Seishin Yakurigaku Zasshi; 1996 Feb; 16(1):11-8. PubMed ID: 8640458
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Reversal of methamphetamine-induced behavioral sensitization by repeated administration of a dopamine D1 receptor agonist.
    Shuto T, Kuroiwa M, Hamamura M, Yabuuchi K, Shimazoe T, Watanabe S, Nishi A, Yamamoto T.
    Neuropharmacology; 2006 Jun; 50(8):991-7. PubMed ID: 16563442
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.